If you're in procurement for a pharmaceutical or medical device company, you've probably seen the name Bemis healthcare packaging paired with Amcor a lot over the last few years—and maybe you're wondering: is the company that acquired them actually giving me better value, or am I just paying for a bigger brand now?
I'm a procurement manager at a mid-sized medical device manufacturer. I’ve managed our packaging budget—roughly $180,000 annually—for about 6 years now, tracking every invoice, comparing vendor quotes, and building our own cost-tracking spreadsheet after getting burned on hidden fees twice. So when Amcor bought Bemis in 2019, I had to figure out: does this acquisition help my bottom line, or not?
This article breaks down the comparison across three concrete dimensions that matter to me as a cost controller:
- Total Cost of Ownership (TCO): base price vs. hidden costs like setup fees and minimums
- Supplier Reliability & Responsiveness: does the combined entity slow things down?
- Product Consistency & Spec Compliance: are the films and pouches the same?
If you're deciding between sticking with the legacy Bemis product line or considering Amcor’s full portfolio, this should help you frame the decision.
Dimension 1: Total Cost of Ownership (TCO) — Legacy Bemis vs. Post-Acquisition Pricing
When I first audited our 2023 spending, I noticed something odd. Our per-unit cost for Bemis healthcare packaging films had stayed flat, but our total invoices were creeping up. That’s when I started digging into the fine print.
Legacy Bemis (pre-2020 contracts):
- Base price for standard barrier film: ~$2.40/lb (for committed volume of 10,000 lbs/quarter)
- Setup fees: $0 (included in quoted price for existing customers)
- Minimum order quantities: 5,000 lbs per SKU
- Rush fees: +25% on base price for 5-day turnaround
Amcor post-acquisition pricing (2023-2024):
- Base price for comparable film: ~$2.55/lb (6% higher)
- Setup fees: $75 per new SKU (plate charges, even for digital)
- Minimum order quantities: 8,000 lbs per SKU (60% higher minimum)
- Rush fees: +35% for same 5-day turnaround
At first glance, the difference is only $0.15/lb. But when you calculate TCO for our quarterly orders of 12,000 lbs across three SKUs:
- Legacy Bemis: $2.40 × 12,000 = $28,800 (no additional fees)
- Amcor: $2.55 × 12,000 = $30,600, plus potentially $225 in setup fees ($75 × 3 SKUs). That’s $1,800 more per quarter—a 6.3% increase hidden in base pricing and minimums.
Now, to be fair, Amcor’s pricing includes their global quality certifications and technical support. If you need those, the premium might be justified. But for a mid-size buyer like us, where we already had a relationship with Bemis, the cost increase was noticeable. We ended up negotiating a blended contract that grandfathers in our old minimums—something I only got because I had 6 years of order data to back up my volume claims.
Dimension 2: Supplier Reliability & Responsiveness — Bigger Network, Slower Service?
This gets into logistics territory, which isn't my core expertise. But from a procurement perspective, I can tell you how vendor delivery promises compare.
When we were purely with Bemis (pre-2019), our account manager was a single point of contact for our region. Lead times for standard Bemis healthcare packaging pouches were reliably 3-4 weeks. If we needed a rush, the same person could authorize it within a day.
Post-acquisition, we were transitioned to an Amcor account team. The team is larger—more technical resources—but slower for day-to-day questions. Our lead times stretched to 4-5 weeks for standard orders. The big benefit is that Amcor’s network means they can pull inventory from other regions if there's a shortage. But for a quarterly order of 12,000 lbs, that's rarely a factor.
The real surprise: responsiveness on spec changes. We needed to change the sealant layer on one of our pouches for a new device. With Bemis, it was a 2-week process: email, sample, quote. With Amcor, it took 6 weeks because the request had to go through their central R&D team. That delay cost us more in project timeline than the price difference on the film itself.
I don't want to overgeneralize—this might just be our experience. But if you're comparing Bemis vs Amcor for new projects, factor in response time as a real cost.
Dimension 3: Product Consistency & Spec Compliance — Same Film, New Label?
For medical device packaging, consistency isn't just preference—it's regulatory. We had validated our process around a specific Bemis film formulation, so changing suppliers would mean re-validation. That’s a $5,000-$10,000 process depending on the complexity.
I initially worried that Amcor might change the formulation to align with their own product lines. But in our testing, the films labeled as the legacy Bemis SKUs were identical—same MVTR, same physical properties. A rep told me that Amcor kept the production lines running and simply added their own quality overlays.
Where it got tricky: The documentation and labeling. Our receiving team noticed that the packaging labels changed format—new lot numbering, different expiration date format. That required a minor update to our SOP and training for the warehouse team. Not a huge cost, maybe $500 in admin time, but annoying when you're used to consistency.
The numbers said stay with the Amcor-supplied legacy Bemis line. My gut said I should be worried about a future transition. I kept asking myself: is the $1,800 quarterly savings worth potentially having to re-validate if Amcor ever phases out the Bemis brand entirely? We decided to stock a 6-month buffer of the critical films—cost us about $2,400 in extra inventory carrying costs—as insurance. So far, that’s been unnecessary, but it gives me peace of mind.
(Prices as of January 2025; verify current rates with your account manager.)
Final Take: When to Stick with Legacy Bemis, When to Go Full Amcor
I can only speak to our context: a mid-size B2B medical device company with predictable quarterly ordering patterns. If you're a large pharma company with global logistics, the calculus might be different. But here's how I'd frame the choice:
Choose legacy Bemis (via Amcor) if:
- You already have validated Bemis films in production
- Your order volumes are under 30,000 lbs/quarter
- You value rapid response on minor spec changes
- You want to avoid re-validation costs
Choose full Amcor portfolio if:
- You need access to a wider range of barrier technologies
- You operate globally and want consistent supply across regions
- You're starting a new project from scratch (no legacy specs)
- Your procurement policy requires a single global supplier
For us, the answer was to stay with the legacy Bemis line delivered by Amcor, but with a negotiated contract that locked in our old minimums and setup fee waivers. That negotiation worked because I had the data: 6 years of order history showing consistent volume, and a spreadsheet that flagged the hidden cost differences. If you're in a similar position, don't just accept the new pricing. Ask for the old terms. You might be surprised what they'll agree to.
Disclaimer: Pricing is for general reference only. Actual prices vary by vendor, specifications, and time of order. Regulatory information is for general guidance only; consult official sources for current requirements.
